Cystatin C concentration was significantly elevated in the patients with a CAD severity score >50% compared to the normal coronary artery patients (2.9 ± 2.2 mg/l vs. 0.7 ± 0.2 mg/l). The gene discussed is CST3; the disease is coronary artery disorder.